|
D55.3 Anemia due to disorders of nucleotide metabolism |
|
D55.8 Other anemias due to enzyme disorders |
|
D55.9 Anemia due to enzyme disorder, unspecified |
|
D56.0 Alpha thalassemia |
|
D56.1 Beta thalassemia |
|
D56.2 Delta-beta thalassemia |
|
D56.3 Thalassemia minor |
|
D56.4 Hereditary persistence of fetal hemoglobin [HPFH] |
|
D56.5 Hemoglobin E-beta thalassemia |
|
D56.8 Other thalassemias |
|
D56.9 Thalassemia, unspecified |
|
D57.00 Hb-SS disease with crisis, unspecified |
|
D57.01 Hb-SS disease with acute chest syndrome |
|
D57.02 Hb-SS disease with splenic sequestration |
|
D57.03 Hb-SS disease with cerebral vascular involvement |
|
D57.09 Hb-SS disease with crisis with other specified complication |
|
D57.1 Sickle-cell disease without crisis |
|
D57.20 Sickle-cell/Hb-C disease without crisis |
|
D57.211 Sickle-cell/Hb-C disease with acute chest syndrome |
|
D57.212 Sickle-cell/Hb-C disease with splenic sequestration |
|
D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement |
|
D57.218 Sickle-cell/Hb-C disease with crisis with other specified complication |
|
D57.219 Sickle-cell/Hb-C disease with crisis, unspecified |
|
D57.3 Sickle-cell trait |
|
D57.40 Sickle-cell thalassemia without crisis |
|
D57.411 Sickle-cell thalassemia, unspecified, with acute chest syndrome |
|
D57.412 Sickle-cell thalassemia, unspecified, with splenic sequestration |
|
D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement |
|
D57.418 Sickle-cell thalassemia, unspecified, with crisis with other specified complication |
|
D57.419 Sickle-cell thalassemia, unspecified, with crisis |
|
D57.42 Sickle-cell thalassemia beta zero without crisis |
|
D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome |
|
D57.432 Sickle-cell thalassemia beta zero with splenic sequestration |
|
D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement |
|
D57.438 Sickle-cell thalassemia beta zero with crisis with other specified complication |
|
D57.439 Sickle-cell thalassemia beta zero with crisis, unspecified |
|
D57.44 Sickle-cell thalassemia beta plus without crisis |
|
D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome |
|
D57.452 Sickle-cell thalassemia beta plus with splenic sequestration |
|
D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement |
|
D57.458 Sickle-cell thalassemia beta plus with crisis with other specified complication |
|
D57.459 Sickle-cell thalassemia beta plus with crisis, unspecified |
|
D57.80 Other sickle-cell disorders without crisis |
|
D57.811 Other sickle-cell disorders with acute chest syndrome |
|
D57.812 Other sickle-cell disorders with splenic sequestration |
|
D57.813 Other sickle-cell disorders with cerebral vascular involvement |
|
D57.818 Other sickle-cell disorders with crisis with other specified complication |
|
D57.819 Other sickle-cell disorders with crisis, unspecified |
|
D58.0 Hereditary spherocytosis |
|
D58.1 Hereditary elliptocytosis |
|
D58.2 Other hemoglobinopathies |
|
D58.8 Other specified hereditary hemolytic anemias |
|
D58.9 Hereditary hemolytic anemia, unspecified |
|
D59.0 Drug-induced autoimmune hemolytic anemia |
|
D59.10 Autoimmune hemolytic anemia, unspecified |
|
D59.11 Warm autoimmune hemolytic anemia |
|
D59.12 Cold autoimmune hemolytic anemia |
|
D59.13 Mixed type autoimmune hemolytic anemia |
|
D59.19 Other autoimmune hemolytic anemia |
|
D59.2 Drug-induced nonautoimmune hemolytic anemia |
|
D59.3 Hemolytic-uremic syndrome |
|
D59.4 Other nonautoimmune hemolytic anemias |
|
D59.5 Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli] |
|
D59.6 Hemoglobinuria due to hemolysis from other external causes |
|
D59.8 Other acquired hemolytic anemias |
|
D59.9 Acquired hemolytic anemia, unspecified |
|
D60.0 Chronic acquired pure red cell aplasia |
|
D60.1 Transient acquired pure red cell aplasia |
|
D60.8 Other acquired pure red cell aplasias |
|
D60.9 Acquired pure red cell aplasia, unspecified |
|
D61.01 Constitutional (pure) red blood cell aplasia |
|
D61.09 Other constitutional aplastic anemia |
|
D61.1 Drug-induced aplastic anemia |
|
D61.2 Aplastic anemia due to other external agents |
|
D61.3 Idiopathic aplastic anemia |
|
D61.810 Antineoplastic chemotherapy induced pancytopenia |
|
D61.811 Other drug-induced pancytopenia |
|
D61.818 Other pancytopenia |
|
D61.82 Myelophthisis |
|
D61.89 Other specified aplastic anemias and other bone marrow failure syndromes |
|
D61.9 Aplastic anemia, unspecified |
|
D62. Acute posthemorrhagic anemia |
|
D63.0 Anemia in neoplastic disease |
|
D63.1 Anemia in chronic kidney disease |
|
D63.8 Anemia in other chronic diseases classified elsewhere |
|
D64.0 Hereditary sideroblastic anemia |
|
D64.1 Secondary sideroblastic anemia due to disease |
|
D64.2 Secondary sideroblastic anemia due to drugs and toxins |
|
D64.3 Other sideroblastic anemias |
|
D64.4 Congenital dyserythropoietic anemia |
|
D64.81 Anemia due to antineoplastic chemotherapy |
|
D64.89 Other specified anemias |
|
D64.9 Anemia, unspecified |
|
D65. Disseminated intravascular coagulation [defibrination syndrome] |
|
D66. Hereditary factor VIII deficiency |
|
D67. Hereditary factor IX deficiency |
|
D68.0 Von Willebrand's disease |
|
D68.1 Hereditary factor XI deficiency |
|
D68.2 Hereditary deficiency of other clotting factors |
|
D68.311 Acquired hemophilia |
